Paper12500513
The influence of methylene blue infusion on cytokine levels during severe sepsis.
Memis D and 4 others. Anaesth Intensive Care, 2002. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. The influence of methylene blue infusion on cytokine levels during severe sepsis. Papers, record 12500513. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12500513
- Disease
- Sepsis231 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytokines | Major topic |
| Methylene Blue | Major topic |
| Sepsis | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Cyclic GMP | |
| Double-Blind Method | |
| Enzyme Inhibitors | |
| Female | |
| Hemodynamics | |
| Humans | |
| Infusions, Intravenous | |
| Interleukins | |
| Male | |
| Methemoglobin | |
| Middle Aged | |
| Prospective Studies | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03120637 | Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue | Results | ClinicalTrials.gov | |
| NCT06306001 | Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock | Results | ClinicalTrials.gov | |
| NCT07040540 | Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General Anesthesia | Background | ClinicalTrials.gov |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42355649 | The Effectiveness of Methylene Blue in Adult Shock: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials. | J Clin Med | 2026 | https://conductscience.org/library/papers/42355649 | PubMed |
| 42165863 | Assessment of methylene blue and NAD on LPS-induced acute brain injury: effects on neuroinflammation, oxidative stress, and blood-brain barrier integrity in a rat endotoxemia model. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42165863 | PubMed |
| 41689248 | Methylene Blue Rescue Therapy for Vasoplegic Shock After Antihypertensive Drug Overdose. | Am J Case Rep | 2026 | https://conductscience.org/library/papers/41689248 | PubMed |
| 40870501 | Methylene Blue Alleviates Inflammatory and Oxidative Lung Injury in a Rat Model of Feces-Induced Peritonitis. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40870501 | PubMed |
| 40764469 | Hemolysis, hemolytic markers, and mortality in sepsis: a scoping review. | Intensive Care Med Exp | 2025 | https://conductscience.org/library/papers/40764469 | PubMed |
| 40718345 | Methylene Blue in Septic Shock: Emerging Evidence, Clinical Applications, and Future Directions. | Cureus | 2025 | https://conductscience.org/library/papers/40718345 | PubMed |
| 40110157 | Blue Hopes, Red Flags: The Methylene Blue Dilemma in Sepsis Shock. | Indian J Crit Care Med | 2025 | https://conductscience.org/library/papers/40110157 | PubMed |
| 40021734 | Predicting responsiveness to fixed-dose methylene blue in adult patients with septic shock using interpretable machine learning: a retrospective study. | Sci Rep | 2025 | https://conductscience.org/library/papers/40021734 | PubMed |
| 39816212 | Haemodynamic management of septic shock. | Burns Trauma | 2025 | https://conductscience.org/library/papers/39816212 | PubMed |
| 39780053 | Comparative study between high and low dose methylene blue infusion in septic cancer patients: a randomized, blinded, controlled study. | BMC Anesthesiol | 2025 | https://conductscience.org/library/papers/39780053 | PubMed |
| 39736782 | Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials. | Crit Care | 2024 | https://conductscience.org/library/papers/39736782 | PubMed |
| 39476299 | Fifty shades of green and blue: autopsy findings after administration of xenobiotics. | Forensic Sci Med Pathol | 2025 | https://conductscience.org/library/papers/39476299 | PubMed |
| 39360775 | Major Publications in the Critical Care Pharmacotherapy Literature: 2023. | Crit Care Explor | 2024 | https://conductscience.org/library/papers/39360775 | PubMed |
| 39334256 | Efficacy of methylene blue in refractory septic shock: study protocol for a multicenter, randomized, placebo-controlled trial. | Trials | 2024 | https://conductscience.org/library/papers/39334256 | PubMed |
| 38904978 | Methylene Blue in Septic Shock: A Systematic Review and Meta-Analysis. | Crit Care Explor | 2024 | https://conductscience.org/library/papers/38904978 | PubMed |
| 38698779 | Methylene blue in sepsis and septic shock: a systematic review and meta-analysis. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38698779 | PubMed |
| 38365828 | Administration of methylene blue in septic shock: pros and cons. | Crit Care | 2024 | https://conductscience.org/library/papers/38365828 | PubMed |
| 38216185 | Effect of methylene blue on outcomes in patients with distributive shock: a meta-analysis of randomised controlled trials. | BMJ Open | 2024 | https://conductscience.org/library/papers/38216185 | PubMed |
| 37719353 | Can Use of Intravenous Methylene Blue Improve the Hemodynamics and Outcome of the Patients with Refractory Septic Shock? An Observational Study. | Indian J Crit Care Med | 2023 | https://conductscience.org/library/papers/37719353 | PubMed |
| 37670332 | Drug diluent and efficacy of methylene blue in septic shock: authors' reply. | Crit Care | 2023 | https://conductscience.org/library/papers/37670332 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| METHYLENE BLUE | CHEMBL550495 | Results | 2 | https://conductscience.org/library/drugs/CHEMBL550495 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12500513
GET https://conductscience.org/api/papers/v1/12500513/cited_by?page=2